 SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 GLOBE NEWSWIRE -- Calithera Biosciences, Inc. Nasdaq: CALA, a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the companys founder, president and chief executive officer, will present at the 2021 Jefferies London Healthcare Conference. 